menu search

Cytokinetics hopes to emulate vertex's market success, share price gains

If Cytokinetics Inc. ( CYTK , Financial) can come anywhere close to achieving its lofty ambition of becoming the Vertex ...

June 23, 2022, 4:05 pm

Anebulo pharmaceuticals to announce topline data for aneb-001 from an ongoing phase 2 clinical trial for acute cannabinoid intoxication on tuesday july 5, 2022

AUSTIN, Texas--(BUSINESS WIRE)--Anebulo pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage bio...

June 23, 2022, 4:00 pm

Wall street analysts predict a 128% upside in centessa pharmaceuticals plc sponsored adr (cnta): here's what you should know

The mean of analysts' price targets for Centessa pharmaceuticals PLC Sponsored ADR (CNTA) points to a 1...

June 23, 2022, 12:24 pm

Xenon's epilepsy candidate rapidly reduces focal onset seizure frequency

Xenon pharmaceuticals Inc (NASDAQ: XENE) announced new efficacy data supporting the Phase 3 developm...

June 23, 2022, 8:24 am

Nrx pharmaceuticals leaders to present at the h.c. wainwright & co. 1st annual mental health conference: neuropsychiatry, psychedelics, and beyond

Company to Present Corporate and Psychiatry Franchise Update During Webcast, June 27, 2022, at 7:00am ET  RADNOR, Pa. , June 23, 2022 /PRNewswire/ -...

June 23, 2022, 7:45 am

Investor views on gsk 'significantly swing towards positive' ahead of haleon spin-off

Hedge funds are increasingly attracted to 'New GSK' as it spins-off its Consumer Healthcare business into Haleon PLC. This and the "markedly improved...

June 23, 2022, 7:01 am

Kalvista pharmaceuticals to present data at the 2022 meeting of the european academy of allergy and clinical immunology (eaaci)

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--EAACI 2022 accepts multiple abstracts from KalVista ...

June 23, 2022, 6:45 am

Xenon pharmaceuticals shares drop on proposed public offering

Xenon pharmaceuticals Inc (NASDAQ: XENE) announced an underwritten public offering of its common shar...

June 22, 2022, 5:31 pm

Avid bioservices to report financial results for quarter and fiscal year ended april 30, 2022 after market close on june 29, 2022

TUSTIN, Calif., June 22, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing o...

June 22, 2022, 4:05 pm

Dogs of the dow are 2022's best in show

All portfolio doctors should prescribe high dividends to remedy rising interest rates and stiff inflation. In 2022, the first year in recent memory po...

June 22, 2022, 2:34 pm

Zynerba's cannabidiol formulated gel shows encouraging action in genetic disease

Zynerba pharmaceuticals Inc (NASDAQ: ZYNE) announced positive top-line results from the Phase 2 INSP...

June 22, 2022, 10:54 am

Zynerba pharmaceuticals reports positive results from phase 2 trial of zygel cbd gel in 22q11.2 deletion syndrome

Zynerba pharmaceuticals (NASDAQ:ZYNE) Inc has announced “very encouraging” data from a trial of its...

June 22, 2022, 8:01 am

Why is acadia pharmaceuticals (acad) stock down 33% today?

Today, investors in Acadia pharmaceuticals and ACAD stock are in selling mode. The FDA gave a thumbs do...

June 21, 2022, 2:58 pm

Astrazeneca, ionis plan to seek fda approval for rare-disease therapy this year

U.S.-listed shares of AstraZeneca AZN, +2.98% were up 2.5% in trading on Tuesday after the company said an experimental therapy for hereditary transth...

June 21, 2022, 11:19 am

Celanese: a closer look at this new buffett holding

Celanese Corp. ( CE , Financial) is a global chemicals leader which focuses on the production of speciality materials and chemical products. It is one...

June 21, 2022, 10:46 am

Ngm biopharmaceuticals: eye disorder data due second half of 2022

Results from the phase 2 CATALINA study using NGM621 for the treatment of patients with Geographic Atrophy are expected in the 2nd half of 2022. Resul...

June 21, 2022, 8:03 am

Kintara therapeutics to present at the alliance global partners summer healthcare conference

SAN DIEGO , June 21, 2022 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a bio...

June 21, 2022, 8:00 am

Regeneron pharmaceuticals: lack of appreciation for the purchase of libtayo

Regeneron acquired the global rights to Libtayo from Sanofi. The deal also brings acceleration of repayments to Sanofi....

June 21, 2022, 6:40 am

Ionq is building the future of computing and is only $5/share, is it enough?

IonQ stock has had a terrible year, declining over 71% as of the market close June 17, 2022. The company is pursuing development of practical quantum ...

June 20, 2022, 5:32 am

Teva pharma trends lower ahead of a key shareholder meeting this week

The Health Care sector has been relatively strong this year amid stock market volatility. Teva pharmaceutical<...

June 19, 2022, 9:54 pm


Search within

Pages Search Results: